4.3 Article

Site-Specific Anticancer Effects of Dietary Flavonoid Quercetin

期刊

出版社

ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
DOI: 10.1080/01635581.2014.864418

关键词

-

资金

  1. NGO Praeventio

向作者/读者索取更多资源

Food-derived flavonoid quercetin, widely distributed in onions, apples, and tea, is able to inhibit growth of various cancer cells indicating that this compound can be considered as a good candidate for anticancer therapy. Although the exact mechanism of this action is not thoroughly understood, behaving as antioxidant and/or prooxidant as well as modulating different intracellular signalling cascades may all play a certain role. Such inhibitory activity of quercetin has been shown to depend first of all on cell lines and cancer types; however, no comprehensive site-specific analysis of this effect has been published. In this review article, cytotoxicity constants of quercetin measured in various human malignant cell lines of different origin were compiled from literature and a clear cancer selective action was demonstrated. The most sensitive malignant sites for quercetin revealed to be cancers of blood, brain, lung, uterine, and salivary gland as well as melanoma whereas cytotoxic activity was higher in more aggressive cells compared to the slowly growing cells showing that the most harmful cells for the organism are probably targeted. More research is needed to overcome the issues of poor water solubility and relatively low bioavailability of quercetin as the major obstacles limiting its clinical use.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Oncology

Xanthohumol: A Metabolite with Promising Anti-Neoplastic Potential

Hardeep S. Tuli, Vaishali Aggarwal, Gaurav Parashar, Diwakar Aggarwal, Nidarshana C. Parashar, Muobarak J. Tuorkey, Mehmet Varol, Katrin Sak, Manoj Kumar, Harpal S. Buttar

Summary: The overwhelming global burden of cancer has presented challenges and opportunities for developing anti-cancer therapies. Phytochemicals have emerged as promising compounds with potential anti-cancer effects, especially in synergy with conventional drugs. Xanthohumol, a prenylated phytoflavonoid, has demonstrated key anti-cancer activities at cellular and molecular levels, making it a potential candidate for inhibiting tumor progression.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2022)

Review Oncology

Gallic Acid: A Dietary Polyphenol that Exhibits Anti-neoplastic Activities by Modulating Multiple Oncogenic Targets

Hardeep Singh Tuli, Hiral Mistry, Ginpreet Kaur, Diwakar Aggarwal, Vivek Kumar Garg, Sonam Mittal, Mukerrem Betul Yerer, Katrin Sak, Md Asaduzzaman Khan

Summary: Phytochemicals, including gallic acid, have been used for thousands of years to prevent cancer and have recently gained interest due to their anti-cancer properties. Gallic acid exerts its anti-cancer effects through various cellular pathways and synergizes with existing chemotherapeutic drugs. Nanotechnology approaches are also discussed to enhance the bioavailability and therapeutic efficacy of gallic acid.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2022)

Review Medicine, Research & Experimental

Galangin: A metabolite that suppresses anti-neoplastic activities through modulation of oncogenic targets

Hardeep Singh Tuli, Katrin Sak, Shubham Adhikary, Ginpreet Kaur, Diwakar Aggarwal, Jagjit Kaur, Manoj Kumar, Nidarshana Chaturvedi Parashar, Gaurav Parashar, Uttam Sharma, Aklank Jain

Summary: This article presents the multifaceted anti-cancer action of propolis-derived flavonoid, galangin, discussing its effects in various cancer cells, including antioxidant, anti-inflammatory, antiproliferative, pro-apoptotic, anti-angiogenic, and anti-metastatic. It also explores the co-effects with standard chemotherapeutic drugs and other natural compounds, as well as modern nanotechnological advancements for overcoming the low bioavailability issue of galangin. Further studies are needed to confirm the anti-cancer potential of galangin in vivo malignant systems, but exploring this natural compound may open new perspectives in molecular oncology.

EXPERIMENTAL BIOLOGY AND MEDICINE (2022)

Review Oncology

Dietary Flavonoids with Catechol Moiety Inhibit Anticancer Action of Bortezomib: What about the other Boronic Acid-based Drugs?

Katrin Sak

Summary: The approval and development of boronic acid-based drugs have sparked great interest in medicinal chemistry. However, potential interactions between these drugs and common dietary flavonoids containing catechol groups remain unclear, which could impact drug efficacy and clinical outcomes.

CURRENT CANCER DRUG TARGETS (2022)

Review Pharmacology & Pharmacy

Anticancer potential of oroxylin A: from mechanistic insight to synergistic perspectives

Hardeep Singh Tuli, Vivek Kumar Garg, Ajay Kumar, Diwakar Aggarwal, Uttpal Anand, Nidarshana Chaturvedi Parashar, Adesh K. Saini, Ranjan K. Mohapatra, Kuldeep Dhama, Manoj Kumar, Tejveer Singh, Jagjit Kaur, Katrin Sak

Summary: This review article provides a comprehensive description of the potential applications of Oroxylin A (OA), a constituent of Scutellariae plants, in the treatment of malignant tumors. It discusses the various mechanisms of action, including antiproliferative, anti-inflammatory, and proapoptotic effects, and explores the synergistic effects with conventional anticancer agents as well as the advantages of nanotechnological methods in OA application.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2023)

Review Toxicology

Molecular mechanisms behind ROS regulation in cancer: A balancing act between augmented tumorigenesis and cell apoptosis

Hardeep Singh Tuli, Jagjit Kaur, Kanupriya Vashishth, Katrin Sak, Ujjawal Sharma, Renuka Choudhary, Tapan Behl, Tejveer Singh, Sheetu Sharma, Adesh K. Saini, Kuldeep Dhama, Mehmet Varol, Gautam Sethi

Summary: ROS plays important roles in living organisms, with moderate levels affecting disease development and excessive levels leading to cell death. Current research is focused on using chemotherapy drugs and herbal agents to induce cancer cell death, while maintaining ROS homeostasis is crucial for cell development and survival.

ARCHIVES OF TOXICOLOGY (2023)

Review Biochemistry & Molecular Biology

Immunotherapeutics in lung cancers: from mechanistic insight to clinical implications and synergistic perspectives

Hardeep Singh Tuli, Vivek K. Garg, Renuka Choudhary, Ashif Iqubal, Katrin Sak, Adesh K. Saini, Reena V. Saini, Kanupriya Vashishth, Kuldeep Dhama, Ranjan K. Mohapatra, Dhruv Sanjay Gupta, Ginpreet Kaur

Summary: Lung cancer is a highly lethal form of cancer with rapidly increasing incidence. Non-small cell lung cancer (NSCLC) accounts for 80-85% of all cases, with adenocarcinoma, squamous cell carcinoma and large cell carcinoma as the main subtypes. Immune checkpoint inhibitors have led to significant advances in the treatment of solid tumors, improving cancer patient survival rates.

MOLECULAR BIOLOGY REPORTS (2023)

Article Oncology

Natural flavonoids exhibit potent anticancer activity by targeting microRNAs in cancer: A signature step hinting towards clinical perfection

Hardeep Singh Tuli, Vivek Kumar Garg, Sakshi Bhushan, Vivek Uttam, Uttam Sharma, Aklank Jain, Katrin Sak, Vikas Yadav, Jose M. Lorenzo, Kuldeep Dhama, Tapan Behl, Gautam Sethi

Summary: Cancer prevalence and incidence rates have been increasing over the past few decades. To combat this disease, it is necessary to explore safer and more effective molecules. Flavonoids, a class of polyphenols, have shown potential against cancer without significant toxicity to normal cells. They modulate microRNAs to enhance drug sensitivity and suppress cancer cell proliferation, metastasis, and angiogenesis. This review comprehensively discusses the structure, chemistry, and effects of flavonoids like quercetin, luteolin, silibinin, genistein, epigallocatechin gallate, and cyanidin on various cancer types. Targeting miRNAs by flavonoids in cancer cells could be a promising approach for future clinical investigations and affirmation.

TRANSLATIONAL ONCOLOGY (2023)

Review Biochemistry & Molecular Biology

Cucurbitacins as Potent Chemo-Preventive Agents: Mechanistic Insight and Recent Trends

Hardeep Singh Tuli, Prangya Rath, Abhishek Chauhan, Anuj Ranjan, Seema Ramniwas, Katrin Sak, Diwakar Aggarwal, Manoj Kumar, Kuldeep Dhama, E. Hui Clarissa Lee, Kenneth Chun-Yong Yap, Sharah Mae Capinpin, Alan Prem Kumar

Summary: Cucurbitacins, a group of highly oxidized tetracyclic triterpenoids found in cucumbers, have potential medical uses. They interact with various cellular targets to inhibit cancer cell growth through induction of apoptosis, cell-cycle arrest, anti-metastasis, and anti-angiogenesis. They may also be used in combination with other drugs to overcome treatment resistance in cancer cells. This study focuses on finding molecular targets for cucurbitacins in suppressing malignant processes.

BIOMOLECULES (2023)

Editorial Material Nutrition & Dietetics

Recommendation to Consume Plant Products for their Health Benefits may Take a Different Perspective with Global Warming

Katrin Sak

Summary: Over the past few decades, the anticancer effects of various plant-derived flavonoids have been extensively studied. Flavonoids, which are synthesized in response to environmental stresses in plants, have diverse biological activities in the human body. They possess antioxidant, anti-inflammatory, antiproliferative, proapoptotic, anti-migratory, anti-invasive, anti-metastatic, and anti-angiogenic properties, which can help prevent and slow the development of different types of cancer. However, global warming may lead to a decrease in the content and composition of flavonoids in plant-based diets, potentially contributing to the increasing worldwide incidence of cancer cases.

CURRENT NUTRITION & FOOD SCIENCE (2023)

Review Pharmacology & Pharmacy

Chemopreventive mechanisms of amentoflavone: recent trends and advancements

Hardeep Singh Tuli, Hemant Joshi, Kanupriya Vashishth, Seema Ramniwas, Mehmet Varol, Manoj Kumar, Isha Rani, Vibha Rani, Katrin Sak

Summary: This review article discusses the anticancer properties of a natural biflavone compound called amentoflavone, derived from various plants such as ginkgo, hinoki, and St. John`s wort. It has been found to suppress malignant growth, induce apoptosis in tumor cells, and inhibit angiogenesis and metastasis. Amentoflavone shows promise as a potential lead compound for the development of novel anticancer drugs, and further in vivo studies and clinical trials are warranted.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2023)

Review Pharmacology & Pharmacy

Apoptotic Mechanisms of Quercetin in Liver Cancer: Recent Trends and Advancements

Gautam Sethi, Prangya Rath, Abhishek Chauhan, Anuj Ranjan, Renuka Choudhary, Seema Ramniwas, Katrin Sak, Diwakar Aggarwal, Isha Rani, Hardeep Singh Tuli

Summary: Due to the rising incidence rates of liver cancer and concerns regarding toxicity of current chemotherapy drugs, there is an increasing need for alternative treatment methods. Quercetin, a flavonoid found in fruits, vegetables, and herbs, has shown promising results in inducing apoptotic cell death in cancer cells. It targets apoptosis-related proteins and has the potential for chemoprevention. This review discusses the mechanisms of action, nanodelivery strategies, and other potential cellular effects of quercetin in liver cancer.

PHARMACEUTICS (2023)

Review Chemistry, Medicinal

Autophagy Induction by Scutellaria Flavones in Cancer: Recent Advances

Hardeep Singh Tuli, Sakshi Bhushan, Ajay Kumar, Poonam Aggarwal, Katrin Sak, Seema Ramniwas, Kanupriya Vashishth, Tapan Behl, Rashmi Rana, Shafiul Haque, Miguel A. Prieto

Summary: This review article focuses on the role of Scutellaria flavones in regulating the autophagic machinery in diverse cancer models, highlighting their potential as lead compounds for the fight against malignant neoplasms. Flavonoids exhibit a dual-edged sword property of acting as both anti- and proautophagic agents.

PHARMACEUTICALS (2023)

Review Pharmacology & Pharmacy

Nanoformulations of quercetin for controlled delivery: a review of preclinical anticancer studies

Hemant Joshi, Dhruv Sanjay Gupta, Ginpreet Kaur, Tejveer Singh, Seema Ramniwas, Katrin Sak, Diwakar Aggarwal, Raunak Singh Chhabra, Madhu Gupta, Adesh K. Saini, Hardeep Singh Tuli

Summary: Quercetin, a natural antioxidant, has shown numerous pharmacological properties in preclinical and clinical research, including anti-inflammatory and anti-cancer effects. Recent studies suggest that using nanoformulations can help overcome the hydrophobicity of quercetin while enhancing its stability and cellular bioavailability.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2023)

Review Chemistry, Multidisciplinary

Metal nanoparticles in cancer: from synthesis and metabolism to cellular interactions

Hardeep Singh Tuli, Ruchira Joshi, Ginpreet Kaur, Vivek Kumar Garg, Katrin Sak, Mehmet Varol, Jagjit Kaur, Sulaiman Ali Alharbi, Tahani Awad Alahmadi, Diwakar Aggarwal, Kuldeep Dhama, Vivek Sheel Jaswal, Sonam Mittal, Gautam Sethi

Summary: Nanotechnology has led to the development of new materials (metal nanoparticles) that have specific applications in healthcare, particularly in the diagnosis and treatment of cancer. Metal nanoparticles can modulate molecular expression in the tumor microenvironment and have anti-cancer effects by inducing apoptosis and cell cycle arrest. They can also inhibit tumor angiogenesis, metastasis, and inflammation, thus preventing cancer proliferation.

JOURNAL OF NANOSTRUCTURE IN CHEMISTRY (2023)

暂无数据